New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials.
about
Management of antithrombotic therapy during cardiac implantable device surgeryApixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based reviewDabigatran-Associated Intracranial Hemorrhage: Literature Review and Institutional ExperienceNovel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative ManagementAntithrombotic management of atrial fibrillation in the elderlyEfficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial FibrillationEfficacy and safety of novel anticoagulants in the elderlyNon-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused ReviewUse of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Capsule commentary on Leiss et al., Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismDirect oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No.Bleeding complications from the direct oral anticoagulants.The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulantsStroke Prevention in Atrial Fibrillation - Outcomes and Future Directions.Real-world characteristics of hospitalized frail elderly patients with atrial fibrillation: can we improve the current prescription of anticoagulants?Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation.Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants.Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians.Cardiac drug therapy-considerations in the elderly.Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.New Oral Anticoagulants: How Do We Use Them Wisely?Evaluation of bleeding in patients receiving direct oral anticoagulants.Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial FibrillUse of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.Minimizing the Risk of Bleeding with NOACs in the Elderly.Update on Anticoagulation: What the Interventional Radiologist Needs to Know.Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban.Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey.Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate presSafety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVincEfficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation.Dilemmas in the management of venous thromboembolism in older patients.Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions.Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population.
P2860
Q26746160-8DC52ACC-BE09-40B0-9384-DB1919CAFF6EQ26783455-358FA620-691E-48E4-A242-27B9E2352662Q26783457-4C09184B-795F-49A1-B185-0D15737EBE37Q26801895-45163990-83DF-4E1D-A7CB-A00F0B40534BQ26827113-240D0240-30BA-4250-9DBC-47EC85AB06CFQ28071543-E5525315-ECD5-4C1F-B5F2-2CF5639A9A48Q28079383-40621DEE-8B4D-4850-B504-1603D44FB54AQ28081918-900A80EA-1630-4B39-A2BD-71890D249434Q31066944-568A8925-2DA3-4980-A78B-59449A95F663Q33427274-C5A91062-C55C-4350-A8EF-D0F79DBB7DA6Q34826282-7B8743BD-E464-49A1-AC82-B5FD913B7924Q35689817-DD9CAB4B-FF5F-40E0-9D07-EF06BD1751BFQ35878677-B84D6F59-D20A-43FC-8531-13F3D8C2B5ACQ36396649-E1395884-83F1-418F-85BB-55921ECF3D93Q36458805-2CC71613-72AE-4E8E-9942-C62D47383B8BQ36784701-8D4DF79C-B894-4B0E-B9EE-9C58F1EA15F1Q36951700-3041781D-D8B6-4FE7-8F66-79AF220E52F9Q37201505-867168C5-E9E1-4F4F-BF20-51533BF897E5Q37437878-C5CEBCD6-72D8-41B9-8C73-37126D50535BQ37613761-90893690-4774-47D4-B172-412637F734B9Q37701918-524B7DF2-AAC5-44D0-90F2-2919335F2C66Q38372780-7273F4C4-9F08-4F63-AB2A-00BB70CF6E1EQ38496232-BA6A1023-5357-4395-B748-273F699568D9Q38560059-C5756BE8-20A8-44D7-B7FF-DD76EF72D9E4Q38598970-AAD7BB3C-2A29-4F54-AFC4-8913FD5146C0Q38665697-C6EEF382-102E-4B2F-AECA-9ED547F84556Q38776019-ADDB2135-C863-466F-B3B6-334F71F3E5FCQ38833382-10EC79E6-6A9B-4ACB-9AC1-A44ECBAD46DBQ38849824-20BED119-BCC0-424A-B596-45C79E3E4F49Q38972270-669E0BCC-52A1-4571-993C-F8BF128B6E43Q40749422-D67EA6B1-C338-4998-94E5-F53B608D0B77Q41507184-D0542383-176A-49D9-9B0B-5A75776B4737Q42676634-BBFBEB56-8C3A-4BF6-AB08-4F1527985B9AQ48721021-76636FE5-5414-465D-8D67-859C950DEB0BQ50019084-C1D1D2FC-0ED2-40B2-B933-3AC8C32972A2Q50093382-0AD37DF8-F906-42CD-B582-C521ADA735B9Q50207168-021DB8E6-8F2A-439B-BCD1-06200A772EAFQ51496815-1C5A22CE-D154-4FAD-A198-17C5EE21F3FAQ55023794-7FDCC187-03B3-489A-8C79-106339CC50F2Q55050376-7082EC65-F7E9-447F-AD8A-A7C22B72FDD9
P2860
New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
New oral anticoagulants in eld ...... analysis of randomized trials.
@ast
New oral anticoagulants in eld ...... analysis of randomized trials.
@en
type
label
New oral anticoagulants in eld ...... analysis of randomized trials.
@ast
New oral anticoagulants in eld ...... analysis of randomized trials.
@en
prefLabel
New oral anticoagulants in eld ...... analysis of randomized trials.
@ast
New oral anticoagulants in eld ...... analysis of randomized trials.
@en
P2093
P2860
P356
P1476
New oral anticoagulants in eld ...... analysis of randomized trials.
@en
P2093
Partha Sardar
Saurav Chatterjee
Shobhana Chaudhari
P2860
P304
P356
10.1111/JGS.12799
P407
P577
2014-05-01T00:00:00Z